CRP and osteosarcoma: The present study demonstrates that elevated ESR, NLR, as well as elevated levels of CRP, neutrophils, and LDH are significantly associated with metastasis in osteosarcoma patients, highlighting the prognostic value of systemic inflammatory markers and their potential role in guiding risk stratification and personalized treatment strategies.